RCM
RGLS
RA Capital Management’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-336,843
| Closed | -$532K | – | 95 |
|
|
2024
Q4 | $532K | Sell |
336,843
-429,991
| -56% | -$679K | 0.01% | 88 |
|
|
2024
Q3 | $1.2M | Sell |
766,834
-5,483,166
| -88% | -$8.61M | 0.01% | 80 |
|
|
2024
Q2 | $11.2M | Hold |
6,250,000
| – | – | 0.15% | 65 |
|
|
2024
Q1 | $18M | Buy |
+6,250,000
| New | +$18M | 0.23% | 66 |
|
|
2016
Q2 | – | Sell |
-1,045,119
| Closed | -$7.24M | – | 37 |
|
|
2016
Q1 | $7.24M | Sell |
1,045,119
-2,437,805
| -70% | -$16.9M | 0.93% | 28 |
|
|
2015
Q4 | $30.4M | Sell |
3,482,924
-556,899
| -14% | -$4.86M | 3.01% | 10 |
|
|
2015
Q3 | $26.4M | Buy |
4,039,823
+249,347
| +7% | +$1.63M | 3.79% | 6 |
|
|
2015
Q2 | $41.5M | Buy |
3,790,476
+199,788
| +6% | +$2.19M | 4.18% | 5 |
|
|
2015
Q1 | $60.8M | Sell |
3,590,688
-1,152,223
| -24% | -$19.5M | 6.04% | 4 |
|
|
2014
Q4 | $76.1M | Buy |
+4,742,911
| New | +$76.1M | 8.18% | 3 |
|